United States Antimony (NYSEAMERICAN:UAMY) Stock Price Down 4.4% - Time to Sell?

Key Points

• Stock action: UAMY fell 4.4% to $6.44 intraday on Thursday with ~2.22M shares traded (down 68% vs. average) and is trading between its 50‑day ($8.56) and 200‑day ($5.13) moving averages.
• Analyst view: The consensus rating is Buy with a consensus target of $6.08 (below the current price), though HC Wainwright recently raised its target to $10.25 and William Blair initiated coverage as "Outperform".
• Fundamentals & insider signal: UAMY reported Q3 EPS of -$0.04 with a negative net margin (-45.32%) and P/E of -153.38, yet CEO Gary C. Evans bought 100,000 shares at $6.13, modestly increasing his stake.

United States Antimony Co. (NYSEAMERICAN:UAMY - Get Free Report)'s stock price dropped 4.4% during mid-day trading on Thursday . The stock traded as low as $6.61 and last traded at $6.4430. Approximately 2,218,748 shares traded hands during mid-day trading, a decline of 68% from the average daily volume of 6,995,270 shares. The stock had previously closed at $6.74.

Analyst Ratings Changes

UAMY has been the topic of several research reports. William Blair assumed coverage on United States Antimony in a report on Monday, October 20th. They set an "outperform" rating on the stock. HC Wainwright lifted their price objective on United States Antimony from $8.50 to $10.25 and gave the company a "buy" rating in a report on Thursday, November 13th. Finally, D. Boral Capital reiterated a "buy" rating and set a $5.00 target price on shares of United States Antimony in a report on Thursday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating and four have given a Buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus target price of $6.08.

United States Antimony Stock Down 9.0%

The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.84 and a current ratio of 6.24. The firm has a market capitalization of $852.02 million, a P/E ratio of -153.38 and a beta of -0.10. The business's fifty day moving average price is $8.56 and its two-hundred day moving average price is $5.13.

United States Antimony (NYSEAMERICAN:UAMY - Get Free Report) last announced its earnings results on Wednesday, November 12th. The company reported ($0.04) earnings per share for the quarter. The firm had revenue of $8.70 million during the quarter. United States Antimony had a negative net margin of 45.32% and a negative return on equity of 16.58%. United States Antimony has set its FY 2026 guidance at EPS. FY 2025 guidance at EPS. Equities analysts expect that United States Antimony Co. will post -0.01 earnings per share for the current fiscal year.

Insider Transactions at United States Antimony

In other United States Antimony news, CEO Gary C. Evans purchased 100,000 shares of the firm's stock in a transaction on Friday, September 26th. The stock was bought at an average cost of $6.13 per share, for a total transaction of $613,000.00. Following the completion of the purchase, the chief executive officer owned 2,378,818 shares in the company, valued at $14,582,154.34. This represents a 4.39% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 4.20% of the stock is owned by corporate insiders.

Institutional Trading of United States Antimony

Several large investors have recently added to or reduced their stakes in UAMY. Nova Wealth Management Inc. lifted its holdings in shares of United States Antimony by 405.0% during the third quarter. Nova Wealth Management Inc. now owns 5,050 shares of the company's stock worth $31,000 after purchasing an additional 4,050 shares during the period. Geneos Wealth Management Inc. acquired a new position in shares of United States Antimony in the 3rd quarter valued at about $49,000. Focus Partners Wealth purchased a new stake in shares of United States Antimony in the third quarter worth about $62,000. Jones Financial Companies Lllp raised its position in United States Antimony by 28.1% during the third quarter. Jones Financial Companies Lllp now owns 10,130 shares of the company's stock valued at $63,000 after acquiring an additional 2,223 shares in the last quarter. Finally, Evernest Financial Advisors LLC acquired a new position in United States Antimony in the third quarter valued at approximately $66,000. Hedge funds and other institutional investors own 9.49% of the company's stock.

About United States Antimony

United States Antimony Corporation produces and sells antimony, silver, gold, precious metals, and zeolite products in the United States, and Canada. It operates through Antimony, Zeolite, and Precious Metals segments. The company offers antimony oxide that is primarily used in conjunction with a halogen to form a synergistic flame retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings, and paper, as well as color fastener in paints and as a phosphorescent agent in fluorescent light bulbs; antimony trisulfide used as a primer in ammunition; and antimony metal for use in bearings, storage batteries, and ordnance.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.